Neurex ziconotide
Executive Summary
Medtronic will market Neurex' neuron specific calcium channel blocker/non-opioid analgesic ziconotide in the U.S., Elan tells Nationsbanc Montgomery Securities Healthcare conference July 16. Medtronic developed the intrathecal pump that will be used with the drug. Newly-acquired Elan subsidiary Neurex will receive 45% of sales revenues. Neurex expects to file a ziconotide NDA for chronic neuropathic/malignant pain in the fourth quarter